David Lovejoy
Net worth: 49 104 $ as of 2024-05-30
Career history of David Lovejoy
Former positions of David Lovejoy
| Companies | Position | Start | End |
|---|---|---|---|
| University of Toronto | Corporate Officer/Principal | - | - |
| PROTAGENIC THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 1994-02-02 | - |
| Founder | 1994-02-02 | - | |
Protagenic Therapeutics, Inc. /Old/
 Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - | - |
Training of David Lovejoy
| University of Victoria | Doctorate Degree |
Statistics
International
| United States | 3 |
| Canada | 3 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PROTAGENIC THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Protagenic Therapeutics, Inc. /Old/
Protagenic Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- David Lovejoy
- Experience
